New Medical Device Commercialization Firm Announces Launch

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

Launching, marketing, and supporting medical devices in the U.S. market can be a daunting, expensive, and time-consuming enterprise, particularly for companies that may not have an existing presence in the U.S. Harrison Bay Life Sciences (HBLS), headquartered in Chattanooga, Tennessee, recently announced the growth of its business that aids medical device companies seeking a commercialization partner who can bring innovative medical products and services to market.

HBLS’s unique infrastructure and experienced team provide medical device startup companies with everything they need to successfully achieve and maintain profitability throughout a product’s lifecycle. HBLS will guide products through market analysis and market development; clinical trials and FDA approval; market entry and promotion; logistics, delivery, and inventory management; and provide exceptional clinical support.

Companies will be able to leverage HBLS’ existing relationships and credentials with hospitals, outpatient surgery centers, group purchasing organizations, and physician practices. They’ll also be able to take advantage of HBLS’ proprietary logistics and fulfillment systems, military-grade cybersecurity protocols and consulting, and remote case/procedure support through advanced remote imaging technologies.

Real-Time Imaging Services & Remote Procedure Support
HBLS’s clients benefit from its remote case/procedure support imaging tool, which allows remote users 360° views of a surgical suite as if they were present. The proprietary software merges and renders simultaneous realities without latency, offering meaningful collaboration around the world. It also features built-in 4D, AR and AI capabilities, including adaptive visualization.

This allows technicians to support sophisticated medical devices and physicians remotely, without the need for travel or physically accessing medical facilities. This will become increasingly important in the post-COVID-19 era, as more medical facilities will increasingly limit access, and as there continues to be local shortages of available medical experts and technicians.



Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.